Condition: Geographic Atrophy Secondary to Age-related Macular Degeneration · Sponsor: Apellis Pharmaceuticals, Inc.
A Phase 2, Randomized, Placebo-controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL-3007 in Combination with Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed with Geographic Atrophy Secondary to Age-Related Macular Degeneration
This description comes directly from the study's public registry record.
Apellis Clinical Trial Information Line · 617-977-5700 · clinicaltrials@apellis.com
Always discuss trial participation with your own doctor first.
| Associated Retina Consultants (01065) | Gilbert, Arizona, United States | Recruiting |
| Barnet Dulaney Perkins Eye Center (01018) | Mesa, Arizona, United States | Recruiting |
| Associated Retina Consultants - Phoenix | Phoenix, Arizona, United States | Recruiting |
| Retinal Research Institute, LLC (01021) | Phoenix, Arizona, United States | Recruiting |
| Research Network Arizona | Scottsdale, Arizona, United States | Recruiting |
| California Retina Consultants (CRC) - Bakersfield Office | Bakersfield, California, United States | Recruiting |
| Retinal Diagnostic Center | Campbell, California, United States | Recruiting |
| The Retina Partners - Encino | Encino, California, United States | Recruiting |
| Retina Consultants of Orange County - Fullerton Office | Fullerton, California, United States | Recruiting |
| Salehi Retina Institute, Inc dba Retina Associate or Southern California (01034) | Huntington Beach, California, United States | Recruiting |
| Salehi Retina Institute, Inc. Dba Retina Associates of Southern California (01034) | Huntington Beach, California, United States | Recruiting |
| California Retina Consultants (01054) | Oxnard, California, United States | Recruiting |
+ 66 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07215390